Martin M. Oken

Overview

Best Publications

• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  Martin M. Oken;Richard H. Creech;Douglass C. Tormey;John Horton

  18078
  Citations

• Prognostic effect of weight loss prior tochemotherapy in cancer patients

  William D. Dewys;Colin Begg;Philip T. Lavin;Pierre R. Band

  3353
  Citations

• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  2983
  Citations

• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

  Richard I. Fisher;Ellen R. Gaynor;Steve Dahlberg;Martin M. Oken

  2926
  Citations

• The national lung screening trial: Overview and study design

  Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  1314
  Citations

• Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

  Philip C Prorok;Gerald L Andriole;Robert S. Bresalier;Saundra S Buys

  1098
  Citations

• Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's Lymphoma

  Jorge J. Yunis;Martin M. Oken;Manuel E. Kaplan;Kathy M. Ensrud

  917
  Citations

• Clinical and biologic implications of recurrent genomic aberrations in myeloma

  Rafael Fonseca;Emily Blood;Montserrat Rue;David Harrington

  886
  Citations

• Screening by Chest Radiograph and Lung Cancer Mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial

  Martin M. Oken;Willam G. Hocking;Paul A. Kvale;Gerald L. Andriole

  817
  Citations

• Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer.

  Jorge J. Yunis;Glauco Frizzera;Martin M. Oken;James McKenna

  754
  Citations

• Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

  Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

  598
  Citations

• A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma.

  Maria Teresa Landi;Nilanjan Chatterjee;Kai Yu;Lynn R. Goldin

  592
  Citations

• Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute-sponsored working group

  Bruce D. Cheson;John M. Bennett;Kanti R. Rai;Michael R. Grever

  578
  Citations

• bcl-2 and Other Genomic Alterations in the Prognosis of Large-Cell Lymphoma

  Jorge J. Yunis;Mary G. Mayer;Mark A. Arnesen;Dorothee P. Aeppli

  441
  Citations

• The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

  Rafael Fonseca;Carina S. Debes-Marun;Elisa B. Picken;Gordon W. Dewald

  406
  Citations

• Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

  Rafael Fonseca;Emily A. Blood;Emily A. Blood;Martin M. Oken;Martin M. Oken;Robert A. Kyle;Robert A. Kyle

  401
  Citations

• Varying intensity of postremission therapy in acute myeloid leukemia.

  Peter A. Cassileth;Elizabeth Lynch;John D. Hines;Martin M. Oken

  400
  Citations

• Multiple myeloma: A review of the epidemiologic literature

  Dominik D. Alexander;Pamela J. Mink;Hans-Olov Adami;Hans-Olov Adami;Philip Cole

  383
  Citations

• Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer

  John K. Gohagan;Pamela M. Marcus;Richard M. Fagerstrom;Paul F. Pinsky

  360
  Citations

• Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia.

  Jorge J. Yunis;Michael Lobell;Mark A. Arnesen;Martin M. Oken

  325
  Citations